Daily Archives: January 24, 2023
WHO | Five billion people unprotected from trans-fat leading to heart disease
24 Jan, 2023 | 14:44h | UTCNews Release: Five billion people unprotected from trans fat leading to heart disease – World Health Organization
Report: Countdown to 2023: WHO report on global trans-fat elimination 2022 – World Health Organization
Commentary: Five Billion People Exposed to Industrially Produced Trans Fats – Health Policy Watch
Related:
WHO: More than 3 billion people protected from harmful trans-fat in their food
Action Package: WHO Plan to Eliminate Trans-fatty Acids from Global Food Supply
WHO Draft Guideline: Saturated Fatty Acid and Trans-fatty Intake for Adults and Children
Banning trans fats in New York prevented thousands of heart attacks
AHA Statement | Surgical management and mechanical circulatory support in high-risk pulmonary embolisms
24 Jan, 2023 | 14:40h | UTCNews Release: New statement suggests more patients may benefit from surgery for pulmonary embolism – American Heart Association
Commentary from one of the authors on Twitter (thread – click for more)
? New @AHAScience Statement on Surgical Management and Mechanical Circulatory Support in High Risk Acute PE!
Presented today #STS2023 by Writing Chair @GoldbergJBCTMD from @WestchesterMed & published in @CircAHA:https://t.co/YjeA8QbHOw
Endorsed by @STS_CTsurgery @ @AATSHQ pic.twitter.com/OhnRXnriq8
— Jay Giri (@jaygirimd) January 23, 2023
ACP Guideline | Nonpharmacologic and pharmacologic treatments of adults in the acute phase of major depressive disorder
24 Jan, 2023 | 14:41h | UTCSee also:
RCT | Outcomes not different with early restrictive vs. liberal fluid management in sepsis-induced hypotension
24 Jan, 2023 | 14:38h | UTCEarly Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Study comparing early interventions for sepsis shows patients have identical outcomes – Vanderbilt University Medical Center
Commentary on Twitter
This trial comparing treatment strategies that emphasized the use of vasopressors or intravenous fluids for early treatment of sepsis-induced hypotension showed no difference in 90-day mortality before discharge home. #SCCM2023 https://t.co/aIymxmBENE pic.twitter.com/18lFQLMBfA
— NEJM (@NEJM) January 22, 2023
SR | Medication review in hospitalized patients to reduce morbidity and mortality
24 Jan, 2023 | 14:37h | UTCMedication review in hospitalised patients to reduce morbidity and mortality – Cochrane Library
Summary: What are the benefits and risks of medication reviews for hospitalized adults? – Cochrane Library
Commentary on Twitter (thread – click for more)
In hospital medication review can help to reduce readmission: updated @CochraneLibrary review summarises latest evidence https://t.co/mrbIZRBs8b Let's look beyond headline & consider applicability….
— Toby Lasserson (@tlassers) January 23, 2023
ChatGPT listed as author on research papers: many scientists disapprove
24 Jan, 2023 | 14:36h | UTCChatGPT listed as author on research papers: many scientists disapprove – Nature
Related: Abstracts written by ChatGPT fool scientists
RCT | 2 days of postoperative antibiotics is noninferior to 5 days in patients with complex appendicitis
24 Jan, 2023 | 14:33h | UTC2 days versus 5 days of postoperative antibiotics for complex appendicitis: a pragmatic, open-label, multicentre, non-inferiority randomised trial – The Lancet (link to abstract – $ for full-text)
Commentary: Trial supports shorter postoperative antibiotics for complex appendicitis – CIDRAP
Commentary on Twitter
After laparoscopic appendicectomy for complex appendicitis, 2 days versus 5 days of intravenous #antibiotics was non-inferior in terms of infectious complications and mortality within 90 days, suggests new Dutch study: https://t.co/oRsf8BQgAd
— The Lancet (@TheLancet) January 19, 2023
Perspective | The case of statins, diabetes, and bias in observational studies
24 Jan, 2023 | 14:35h | UTCThe Case of Statins, Diabetes, and Bias in Observational Studies – Sensible Medicine
FDA no longer needs to require animal tests before human drug trials
24 Jan, 2023 | 14:32h | UTCFDA no longer needs to require animal tests before human drug trials – Science
See also: The FDA no longer requires all drugs to be tested on animals before human trials – NPR
Cohort Study | The temporal relationship between severe mental illness diagnosis and chronic physical comorbidity
24 Jan, 2023 | 14:31h | UTCCommentary: Severe mental illness and comorbid chronic physical illness: the clock’s ticking – The Mental Elf
Commentary on Twitter
"Elevated odds of multiple conditions at the point of severe mental illness diagnosis suggest that early intervention on physical health parameters is necessary to reduce morbidity and premature mortality."
New research Article @NaomiLaunders @J_F_Hayes https://t.co/Th4b4IPV1l
— The Lancet Psychiatry (@TheLancetPsych) July 25, 2022
2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis
24 Jan, 2023 | 14:29h | UTCKey Points: 2023 ACC Expert Consensus on Cardiac Amyloidosis – American College of Cardiology
Commentary on Twitter
.@ACCinTouch's ? Expert Consensus Decision Pathway provides practical and timely guidance on the diagnosis and management of cardiac #amyloidosis, with an emphasis on comprehensive multidisciplinary care.
Learn more: https://t.co/1SunbtuQpO#JACC #CardioOnc #CardioTwitter pic.twitter.com/DLvFUpajHC
— JACC Journals (@JACCJournals) January 23, 2023
ASCO Guideline | Management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients
24 Jan, 2023 | 14:28h | UTC
RCT | Low-dose exercise provides similar benefits as high-dose exercise in patients with knee osteoarthritis
24 Jan, 2023 | 14:26h | UTCHigh- Versus Low-Dose Exercise Therapy for Knee Osteoarthritis: A Randomized Controlled Multicenter Trial – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentary: Low- vs High-Dose Exercise Programs Yielded Similar Benefits in Patients with Knee Osteoarthritis – HCP Live
Review | Common sleep disorders in children
24 Jan, 2023 | 14:22h | UTCCommon Sleep Disorders in Children – American Family Physician
Note: AFP provides superb review articles that are freely available one year after publication.
M-A | Assessing the diagnostic performance of new commercial IGRAs for Mycobacterium tuberculosis infection
24 Jan, 2023 | 14:25h | UTC
Commentary on Twitter
Assessing the diagnostic performance of new commercial IGRAs for Mycobacterium tuberculosis infection: a systematic review and meta-analysis
✅ Just Accepted
? Open Access
? https://t.co/8eO3ugZdfl pic.twitter.com/Fc2AjJyIw9— Clinical Infectious Diseases (@CIDJournal) January 23, 2023
M-A | Diagnostic value of four biomarkers in detecting neonatal sepsis in low- and middle-income countries
24 Jan, 2023 | 14:21h | UTC
M-A | Metabolic side effects in persons with schizophrenia during mid- to long-term treatment with antipsychotics
24 Jan, 2023 | 14:23h | UTCCommentary: Metabolic Side Effects of Antipsychotics Vary, Meta-Analysis Finds – Psychiatric News Alert
Single-arm phase 2 study | Neoadjuvant pembrolizumab in localized microsatellite instability high/deficient mismatch repair solid tumors
24 Jan, 2023 | 14:19h | UTCNeoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors – Journal of Clinical Oncology (link to abstract – $ for full-text)
Commentary: Neoadjuvant Pembrolizumab in Localized MSI-H/dMMR Solid Tumors – The ASCO Post
M-A | Incidence of acute kidney injury in hospitalized children
24 Jan, 2023 | 14:18h | UTCIncidence of Acute Kidney Injury in Hospitalized Children: A Meta-analysis – Pediatrics
RCT | Intracorporeal vs. extracorporeal anastomosis in robotic right colectomy
24 Jan, 2023 | 14:17h | UTCIntracorporeal Versus Extracorporeal Anastomosis in Robotic Right Colectomy: A Multicenter, Triple-blind, Randomized Clinical Trial – Annals of Surgery (link to abstract – $ for full-text)
Cohort Study | Biomarker trends, incidence, and outcomes of immune checkpoint inhibitor–induced myocarditis
24 Jan, 2023 | 14:16h | UTCCommentary: Biomarker Trends of Immune Checkpoint Inhibitor–Induced Myocarditis – American College of Cardiology
Commentary from the author on Twitter
Our work is now published in @JACCJournals!
ICI #myocarditis rarely occurs in isolation. Elevations in routinely measured biomarkers should prompt further testing for cardiac injury? @salimhayek @umichCVC @UMRogelCancer
Check it out?https://t.co/6o8k4Pbp8J pic.twitter.com/cJzgpqPkL0
— Alexi Vasbinder, PhD, RN (@Avasbind) December 20, 2022
Cohort Study | Alcohol abstinence improves prognosis across all stages of portal hypertension in alcohol-related cirrhosis
24 Jan, 2023 | 14:14h | UTC
RCT | Breast-cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection vs. standard surgical treatment of axilla
24 Jan, 2023 | 14:15h | UTC
Commentary on Twitter
New & available #OpenAccess | Occurrence of breast-cancer–related #lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two-arm randomized clinical trial https://t.co/fXB7PfysCH @OncoAlert pic.twitter.com/wWNhC9BMvY
— ACS Journal Cancer (@JournalCancer) October 20, 2022
RCT | Effect of a multicomponent intervention delivered on a web-based platform on hypertension control
24 Jan, 2023 | 14:12h | UTC
Commentary on Twitter
Cluster RCT: A multicomponent intervention aided by web-based platform improved blood pressure control vs. usual care in China. https://t.co/bsfK5TF1hs
— JAMA Network Open (@JAMANetworkOpen) December 7, 2022
Retrospective Study | Serial troponin-T and long-term outcomes in suspected acute coronary syndrome
24 Jan, 2023 | 14:09h | UTC
Commentary on Twitter
Serial troponin-T and long-term outcomes in suspected acute coronary syndrome https://t.co/cTm1fJTuKl#AHA22 @ehj_ed @rladeiraslopes pic.twitter.com/0p8cO8zhzi
— European Society of Cardiology Journals (@ESC_Journals) November 7, 2022